GLABF (Gemina Laboratories) Net Debt Paydown Yield % : 26.09% (As of Jul. 02, 2026)


What is Gemina Laboratories Net Debt Paydown Yield %?

Gemina Laboratories GLABF -27.59% Net Debt Paydown Yield % is 26.09% as of Jul. 02, 2026. The stock has 2 warning signs investors should review.

Net Debt Paydown Yield % is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. It is a measure of a company's willingness and ability to reduce its debt. As of today, Gemina Laboratories's Net Debt Paydown Yield % was 26.09%.


Gemina Laboratories  (OTCPK:GLABF) Net Debt Paydown Yield % Explanation

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced. In other words, it is a measure of the willingness and ability of a firm's management to pay down debt. Companies that have high debt paydown yields indicate that they are more aggressive with paying down debt.

In the calculation of Net Debt Paydown Yield %, we use the reductions of TTM average total debt one-year-ago and TTM average total debt at present, divided by its Market Cap.

We calculating the TTM average debt by adding up the total debt, calculated by the sum of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation, in the trailing twelve months(TTM) divided by the counts of the total debt, accoring to the company's report frequency.


Gemina Laboratories Net Debt Paydown Yield % Related Terms


Gemina Laboratories Net Debt Paydown Yield % Historical Data

* Premium members only.

The historical data trend for Gemina Laboratories's Net Debt Paydown Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories Net Debt Paydown Yield % Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24 Jan25
Net Debt Paydown Yield %
0.00 0.00 -0.17 -0.61 -2.25

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
Net Debt Paydown Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.70 -2.25 -0.51 0.10 1.98

GLABF vs VRTX, REGN, ALNY: Net Debt Paydown Yield % Comparison

For the Biotechnology subindustry, Gemina Laboratories's Net Debt Paydown Yield %, along with its competitors' market caps and Net Debt Paydown Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gemina Laboratories Net Debt Paydown Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gemina Laboratories's Net Debt Paydown Yield % distribution charts can be found below:

* The bar in red indicates where Gemina Laboratories's Net Debt Paydown Yield % falls into.



Gemina Laboratories Net Debt Paydown Yield % Calculation

Gemina Laboratories's Net Debt Paydown Yield % for the quarter that ended in Oct. 2025 is calculated as:

Net Debt Paydown Yield %
=( TTM Average Debt   (1-Year Ago))-TTM Average Debt )/Market Cap
=( 0.8-0.35 )/26.3327669
=1.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Net Debt Paydown Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.

What does a Net Debt Paydown Yield % of 26.09% mean?
Gemina Laboratories (GLABF) has a Net Debt Paydown Yield % of 26.09% as of Jul. 02, 2026. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on Gemina Laboratories and its competitors.
Is Gemina Laboratories' Net Debt Paydown Yield % too high?
Gemina Laboratories' current Net Debt Paydown Yield % is 26.09%. The Biotechnology industry median Net Debt Paydown Yield % is 0.03. Gemina Laboratories' value of 26.09% is 86866.7% above this industry median.
How does Gemina Laboratories' Net Debt Paydown Yield % compare to VRTX and REGN?
Gemina Laboratories' Net Debt Paydown Yield % of 26.09% can be compared against companies in the Biotechnology industry. The industry median Net Debt Paydown Yield % is 0.03. Gemina Laboratories' value of 26.09% is 86866.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Debt Paydown Yield % for a Biotechnology company?
The median Net Debt Paydown Yield % among Biotechnology companies is 0.03, based on 1,164 companies in the industry. Companies in the top quartile (top 25%) have a Net Debt Paydown Yield % significantly above this median, while those in the bottom quartile fall well below. However, Net Debt Paydown Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gemina Laboratories's current Net Debt Paydown Yield % of 26.09% is 86866.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Debt Paydown Yield % mean?
A high Net Debt Paydown Yield % can signal that a stock is expensive relative to its fundamentals. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on Gemina Laboratories and its competitors. For the Biotechnology industry, the median Net Debt Paydown Yield % is 0.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gemina Laboratories's current Net Debt Paydown Yield % is 26.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gemina Laboratories stock overvalued right now?
Gemina Laboratories (GLABF) has a current Net Debt Paydown Yield % of 26.09%. The current Net Debt Paydown Yield % is 26.09% and 86866.7% above the Biotechnology industry median of 0.03. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Debt Paydown Yield % calculated?
Net Debt Paydown Yield % is calculated from a company's financial statements. For Gemina Laboratories (GLABF), the current Net Debt Paydown Yield % is 26.09% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gemina Laboratories Business Description

Address 3600 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.